GW Cannabinoid Drug Fails Cancer Pain Trial
GW Pharmaceuticals reported top-line results from the first of three Phase 3 trials for Sativex.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 275Wells Fargo’s Top Biotech Stocks for 2015
ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that the biotech…
Is Immunomedics Worth 50% More?
After Immunomedics announced that it had appointed a new chief medical officer, Wells Fargo issued an analyst call implying upside of over 50%.
Analyst’s 8 Top Health Care Stocks for 2015
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
Is a Generic Diovan for You?
What are investors, and patients, supposed to think when is launching a generic version of Diovan?
Rite Aid Scores New Street-High Analyst Price Target
Pharmacy and drug store player Rite Aid now has a new street-high analyst target price from Credit Suisse.
New Biotech ETF Hits the Market
The ALPS Medical Breakthroughs ETF debuted on the market Wednesday and is focused on research and development opportunities in biotechnology and pharmaceutical industries.
The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
Out of 28 biotech stocks with market capitalization rates north of $300 million that were up 100% or more in 2014, seven of them were up 300% or more.
Flex Pharma Files for IPO
Flex Pharma Inc. has filed with the Securities and Exchange Commission (SEC) for its initial public offering.
Is Gilead Already Coming Back Into Favor?
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?
5 Top Pharmaceutical Stock Picks for 2015
In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.
Analysts Predict Big Value Trap for Gilead Investors
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
RBC’s 5 Top Biotech Stocks to Buy for 2015
One sector that could be poised to do well could be the biotech arena, and the team at RBC has five top stocks for investors to focus on as best ideas.
What the AbbVie and Express Script Deal Means for Gilead
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
Merrill Lynch’s Top Health Care Stock Picks for 2015
24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.